Insights

Clinical-stage partnerships Redx Pharma is a clinical-stage biotechnology company with active Phase 2 programs in ROCK inhibitors for fibrosis and a Phase 2 oncology program, presenting multiple collaboration and licensing opportunities across early to mid-stage drug development.

Strategic asset divestiture The company recently sold its KRAS inhibitor program to Jazz Pharmaceuticals for upfront and milestone payments, signaling openness to strategic exits or co-development deals and creating potential for monetizable collaborations on other assets.

Fibrosis and GI focus With RXC007 targeting idiopathic pulmonary fibrosis and RXC008 targeting Crohn’s disease, Redx has a clear nexus in fibrotic and gastrointestinal indications, offering entry points for CRO partnerships, translational science collaborations, or co-development financing in these therapeutic areas.

Cumberland leadership Recent senior clinical leadership additions and a growing scientific team at Alderley Park suggest an expanding clinical execution capability, making Redx an attractive partner for CRO services, clinical trial accelerations, or joint development programs.

Financial and market signals With modest revenue and substantial funding, plus ongoing interest from potential acquirers and alliances, there is a favorable environment for securitized licensing deals, milestone-driven collaborations, or revenue-sharing arrangements around existing and pipeline programs.

Similar companies to Redx Pharma

Redx Pharma Tech Stack

Redx Pharma uses 8 technology products and services including Hotjar, Amazon Web Services, WordPress, and more. Explore Redx Pharma's tech stack below.

Media & News

Redx Pharma's Email Address Formats

Redx Pharma uses at least 4 email formats:
Redx Pharma Email FormatsExamplePercentage
F.Last@redxpharma.comJ.Doe@redxpharma.com
94%
First.Last@redxpharma.comJohn.Doe@redxpharma.com
3%
LastFi@redxpharma.comDoeJo@redxpharma.com
1%
FiLast@redxpharma.comJoDoe@redxpharma.com
2%

Frequently Asked Questions

What is Redx Pharma's phone number?

Minus sign iconPlus sign icon
You can contact Redx Pharma's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Redx Pharma's official website and social media links?

Minus sign iconPlus sign icon
Redx Pharma's official website is redxpharma.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Redx Pharma generate?

Minus sign iconPlus sign icon
As of October 2026, Redx Pharma's annual revenue is estimated to be $1M - $10M.

What is Redx Pharma's SIC code and NAICS code?

Minus sign iconPlus sign icon
Redx Pharma's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Redx Pharma have currently?

Minus sign iconPlus sign icon
As of October 2026, Redx Pharma has approximately 36 employees across 4 continents, including Europe, Asia and North America. Key team members include Chief Executive Officer: L. A., Chief Operating Officer: J. M. and Chief Scientific Officer: C. G. P. Explore Redx Pharma's employee directory with LeadIQ.

What industry does Redx Pharma belong to?

Minus sign iconPlus sign icon
Redx Pharma operates in the Pharmaceutical Manufacturing industry.

What technology does Redx Pharma use?

Minus sign iconPlus sign icon
Redx Pharma's tech stack includes Hotjar, Amazon Web Services, WordPress, Redis, Microsoft 365, Google Cloud, Box and DigitalOcean Web Hosting.

What is Redx Pharma's email format?

Minus sign iconPlus sign icon
Redx Pharma's email format typically follows the pattern of F.Last@redxpharma.com. Find more Redx Pharma email formats with LeadIQ.

How much funding has Redx Pharma raised to date?

Minus sign iconPlus sign icon
As of October 2026, Redx Pharma has raised $103M in funding. The last funding round occurred on May 19, 2022 for $44M.

When was Redx Pharma founded?

Minus sign iconPlus sign icon
Redx Pharma was founded in 2010.
Redx Pharma logo

Redx Pharma

Pharmaceutical ManufacturingEngland, United Kingdom11-50 Employees

Redx Pharma is a clinical-stage biotechnology company focused on discovering and developing novel small-molecule therapeutics for cancer and fibrotic diseases. The company operates from Alderley Park in Cheshire, England, a site described as the UK’s largest single-site life science campus, where its team brings together medicinal chemistry, biology and clinical development expertise. Its portfolio includes RXC007, a ROCK2 inhibitor studied for idiopathic pulmonary fibrosis that progressed to Phase 2 in 2022, RXC008, a GI-targeted ROCK inhibitor for fibrostenotic Crohn's disease that began Phase 1 in 2024, and RXC004, a Porcupine inhibitor in oncology that entered Phase 2 in 2021. 

Redx relies on translational science and medicinal chemistry to advance compounds against validated targets. A recent development is the launch of the RXC008 Phase I trial in early 2024.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $103M

    Redx Pharma has raised a total of $103M of funding over 8 rounds. Their latest funding round was raised on May 19, 2022 in the amount of $44M as a Post IPO Equity.

  • $1M - $10M

    Redx Pharma's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.